Search for Clinical Trial Results

Sponsored By

Neurodegeneration With Brain Iron Accumulation - 8 Studies Found

Status Study
Active, not recruiting Study Name: Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
Condition: Pantothenate Kinase-Associated Neurodegeneration
Date: 2014-06-05
Interventions:
  • Drug: Deferiprone oral solution

Completed Study Name: A Two-arm Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
Condition: Pantothenate Kinase-Associated Neurodegeneration
Date: 2012-12-03
Interventions:
  • Drug: Deferiprone oral solution

Recruiting Study Name: Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)
Condition: Pantothenate Kinase-associated Neurodegeneration (PKAN)
Date: 2013-04-18
Available Study Name: Compassionate Use of Deferiprone in Patients With PKAN
Condition: Pantothenate Kinase-Associated Neurodegeneration
Date: 2015-12-17
Interventions: Drug: Deferiprone Deferiprone oral solution (80 mg/mL)
Recruiting Study Name: Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Patients
Condition: Pantothenate Kinase-Associated Neurodegeneration
Date: 2016-12-02
Interventions:
  • Drug: fosmetpantotenate (RE-024)

Recruiting Study Name: NBIAready: Online Collection of Natural History Patient-reported Outcome Measures
Condition: Neurodegeneration With Brain Iron Accumulation (NBIA)
Date: 2015-10-23
Active, not recruiting Study Name: Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)
Condition:
  • Neurodegenerative Disease
  • Iron Overload

Date: 2009-05-21
Interventions: Drug: Deferiprone 15 mg/Kg/twice for 1 year Other Na